ArticleDermatologic therapy2024

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Jenna Mandel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.